Matt Cross

Stock Analyst at Alliance Global Partners

(0.03)
# 4,476
Out of 4,479 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

1 Stocks

Syros Pharmaceuticals
May 17, 2022
Maintains: Buy
Price Target: $140$100
Current: $5.00
Upside: +1,900.00%